Theoretical considerations on the topological organization of receptor mosaics

Current Protein and Peptide Science

Volumn 10, Issue 6, 2009, Pages 559-569

  Agnati, Luigi Francesco ^a   Fuxe, Kjell ^b   Woods, Amina S ^c   Genedani, Susanna ^a   Guidolin, Diego ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

A2A D2 CB1 receptor trimer; mGLU5 D2 A2A receptor trimer; Receptor bioinformatics analysis; Receptor mosaic; Receptor topology

Indexed keywords

ADENOSINE A2A RECEPTOR; CANNABINOID 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; METABOTROPIC RECEPTOR 5;

ALLOSTERISM; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; EXTRACELLULAR SPACE; HUMAN; INTRACELLULAR SPACE; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE;

ALLOSTERIC REGULATION; ANIMALS; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 73549120626     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920309789630606     Document Type: Article

References (77)

1. Agnati, L.F.; Fuxe, K. Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro. Biosci Rep., 1983, 3, 1101-1105.
2. Fuxe, K.; Agnati, L.F. Receptor-receptor interactions in the central nervous system: a new integrative mechanism in synapses. Med. Res. Rev., 1985, 5, 441-482.
3. Fuxe, K.; Agnati, L.F. Receptor-Receptor Interactions: a New Intramembrane Integrative Mechanism, MacMillan: London, 1987, pp. 14-18.
4. Agnati, L. F.; Ferré, S.; Lluis, C.; Franco, R.; Fuxe, K. Molecular mechanisms and therapeutical implications of intramembrane receptor / receptor interactions among heptahelical receptors with examples from the striopallidal GABA neurons. Pharmacol. Rev., 2003, 55, 509-550.
5. Agnati, L.F. ; Fuxe, K.; Zoli, M.; Ozini, I.; Toffano, G.; Ferraguti, F. A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats: evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission Acta Physiol. Scand., 1986, 128, 201-207.
6. Fuxe, K.; Agnati L.F.; Martire, M.; Neumeyer, A.; Benfenati, F.; Frey, P. Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity. Acta Physiol. Scand., 1986, 126, 147-149.
7. Fuxe, K.; Agnati, L.F.; Härfstrand, A.; Zoli, M.; von Euler, G.; Grimaldi, R.; Merlo Pich, E.; Bjelke, B.; Eneroth, P.; Benfenati, F. On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states: focus on volume transmission and neuropeptide Y/alpha 2 receptor interactions. Ann. NY Acad. Sci., 1990, 579, 28-67.
8. Fuxe, K.; von Euler, G.; van der Ploeg, I.; Fredholm, B.B.; Agnati, L.F. Pertussis toxin treatment counteracts the cardiovascular effects of neuropeptide Y and clonidine in the awake unrestrained rat. Neurosci. Lett., 1989, 101, 337-341.
9. Yang, S.N.; Fior, D.R.; Hedlund, P.B.; Agnati, L.F.; Fuxe, K. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii. Eur. J. Pharmacol., 1994, 271, 201-212.
10. Boyd, C.A.R.; Noble, D. The Logic of Life: The Challenge of Integrative Physiology, Oxford University Press: Oxford, 1993.
11. Agnati, L.F.; Fuxe, K.; Zoli, M.; Rondanini, C.; Ögren, S.O. New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram.Med. Biol., 1982, 60, 183-190.
12. Agnati, LF.; Santarossa, L.; Benfenati, F.; Ferri, M.; Morpurgo, A.; Apolloni, B.; Fuxe K. In From Synapses to Rules; Apolloni, B.; Kurfes, F., Eds; Kluwer Academic/Plenum Publishers: New York, 2002, pp. 165-196.
13. Agnati, LF.; Ferré, S.; Leo, G.; Lluis, C.; Canela, E.I.; Franco, R.; Fuxe K. On the molecular basis of the receptor mosaic hypothesis of the engram. J. Mol. Cell. Neurobiol., 2004, 24, 501-516.
14. Agnati, L.F.; Santarossa, L.; Genedani, S.; Canela, E.I.; Leo ,G.; Franco, R.; Woods, A.; Lluis, C.; Ferrè, S.; Fuxe, K. In Computational Neuroscience: Cortical Dynamics, Lecture Notes in Computer Sciences; Erdi, P.; Esposito, A.; Marinaro, M.; Scarpetta, S., Eds; Springer: Berlin, 2004, pp. 24-54.
15. Agnati, L.F.; Tarakanov, A.O.; Ferré, S.; Fuxe, K.; Guidolin, D. Receptor-receptor interaction, receptor mosaics and basic principles of molecular network organization. Possible implications for drug development. J. Mol. Neurosci., 2005, 26, 193-208.
16. Agnati, L.F.; Leo, G.; Zanardi, A.; Genedani, S.; Rivera, A.; Fuxe, K.; Guidolin, D. Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol., 2006, 187, 329-344.
17. Agnati, L.F.; Guidolin, D.; Leo, G.; Fuxe, K. A boolean network modelling of receptor mosaics: relevance of topology and cooperativity. J. Neural. Transm., 2007, 114, 77-92.
18. Agnati, L.F.; Guidolin, D.; Fuxe, K. The brain as a system of nested but partially overlapping networks: heuristic relevance of the model for brain physiology and pathology. J. Neural. Transm., 2007, 114, 3-19.
19. Agnati, L.F.; Guidolin, D.; Carone, C.; Dam, M.; Genedani, S.; Fuxe, K. Understanding neural molecular networks builds on neural network architecture. Brain Res. Rev., 2008, 58, 379-399.
20. Agnati, L.F.; Guidolin, D.; Genedani, S.; Ferré, S.; Bigiani, A.; Woods, A.; Fuxe, K. How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. J. Mol. Neurosci., 2005, 26, 133-154.
21. Watts, D.J.; Strogatz, S.H. Collective dynamics of small world networks. Nature, 1998, 393, 440-442.
22. Kenakin, T. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol. Sci., 2003, 24, 346-354.
23. Park, P.S.; Filipek, S.; Wells, J.W.; Palczewski, K. Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry, 2004, 21, 15643-15656.
24. Breitwieser, G.E. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ. Res., 2004, 94, 17-27.
25. Gurevich, V.V.; Gurevich, E.V. GPCR monomers and oligomers: it takes all kinds. Trends Neurosci., 2008, 31, 74-81.
26. Ofran, Y; Rost, B. Protein-protein interaction hotspots carved into sequences. PLoS Comput. Biol. 2007, 3, e119.
27. Agnati, L.F.; Ferré, S.; Cortelli, P.; Fuxe, K. A brief appraisal on some aspects of the receptor-receptor interaction. Neurochem. Int., 1995, 27, 139-146.
28. Agnati, L.F.; Leo, G.; Genedani, S.; Andreoli, N.; Marcellino, D.; Woods, A.; Piron, L.; Guidolin, D.; Fuxe, K. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Res. Rev., 2008, 58, 459-474.
29. Thummer, R.P.; Campbell, M.P.; Dean, M.K.; Frusher, M.J.; Scott, P.D.; Reynolds, CA. Entropy and oligomerization in GPCRs. J. Mol. Neurosci., 2005, 26, 113-122.
30. Milligan, G. Opioid receptors and their interacting proteins. Neuromol. Med., 2005, 7, 51-59.
31. Ciruela, F.; Burgueño, J.; Casadó, V.; Canals, M.; Marcellino, D.; Goldberg, S.R.; Bader, M.; Fuxe, K.; Agnati, L.F.; Lluis, C.; Franco, R.; Ferré, S.; Woods, A.S. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization: direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem., 2004, 76, 5354-5363.
32. Agnati, L.F.; Ferre, S.; Genedani, S.; Leo, G.; Guidolin, D.; Filaferro, M.; Carriba, P.; Casado, V.; Lluis, C.; Franco, R.; Woods, A.S.; Fuxe K. Allosteric modultion of dopamine D2 receptors by homocysteine. J. Proteome Res., 2006, 5, 3077-3083.
33. Karnik, S.S.; Gogonea, C.; Patil, S.; Saad, Y.; Takezako, T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol. Metab., 2003, 14, 431-437.
34. Stanfield, P. Voltage sparks a GPCR. Nat. Cell Biol., 2006, 8, 1323-1325.
35. Gouldson, P.R.; Higgs, C.; Smith, R.E.; Dean, M.K.; Gkoutos, G.V.; Reynolds, C.A. Dimerization and domain swapping in G-protein-coupled receptors: a computational study. Neuropsychopharmacology, 2000, 23, S60-S77.
36. Thévenin, D.; Roberts, M.F.; Lazarova, T.; Robinson, C.R. Identifying interactions between transmembrane helices from the adenosine A2A receptor. Biochemistry, 2005, 44,16239-16245.
37. Agnati, L.F.; Fuxe, K.; Ferre, S. How receptor mosaics decode transmitter signals. Possible relevance of cooperativity. Trends Biochem. Sci., 2005, 30, 188-193.
38. Jaffe, E.K. Morpheeins--a new structural paradigm for allosteric regulation. Trends Biochem. Sci., 2005, 30, 490-497.
39. Fuxe, K.; Agnati, L.F.; Franco, R.; Roberts, D.C.; Tanganelli, S.; Bader, M.; Huebner, N.; Schiffmann, S.; Scheel-Kruger, J.; Stromberg, I.; Marsden, C.; Filip, M.; Jaber, M.; Bergquist, J. EU DDTOMICS. proposal N 004863, LifeSciHealth-I, 2003, OJ 2003/C164,FP6-2003.
40. Fuxe, K.; Ferre, S.; Woods, A.; Rivera, A.; Hoistad, M.; Franco, R.; Kehr, J.; Agnati, L.F. Monitoring Molecules in Neuroscience. Karolinska University Press : Stockholm, 2003; pp. 199-202
41. Kearn, C.S.; Blake-Palmer, K.; Daniel, E.; Mackie, K.; Glass, M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol., 2005, 67, 1697-1704.
42. Marcellino, D.; Carriba, P.; Filip, M.; Borgkvist, A.; Frankowska, M.; Bellido, I.; Tanganelli, S.; Muller, C.E.; Roberts, D.C.; Fisone, G.; Lluis, C.; Agnati, L.; Franco, R.; Fuxe, K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers: a combined neurochemical and behavioral analysis. Neuropharmacology, 2008, 54, 815-823.
43. Carriba, P.; Ortiz, O.; Patkar, K.; Justinova, Z.; Stroik, J.; Themann, A.; Muller, C.; Woods, A.S.; Hope, B.T.; Ciruela, F.; Casado, V.; Canela, E.I.; Lluis, C.; Goldberg, S.R.; Moratalla, R.; Franco, R.; Ferre, S. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology, 2007, 32, 2249-2259.
44. Andersson, M.; Usiello, A.; Borgkvist, A.; Pozzi, L.; Dominguez, C.; Fienberg, A.A.; Svenningsson, P.; Fredholm, B.B.; Borrelli, E.; Greengard, P.; Fisone, G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J. Neurosci., 2005, 25, 8432-8438.
45. Borgkvist, A.; Marcellino, D.; Fuxe, K.; Greengard, P.; Fisone, G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology, 2008, 54, 31-35.
46. Fuxe, K.; Marcellino, D.; Rivera, A.; Diaz-Cabiale, Z.; Filip, M.; Gago, B.; Roberts, D.C.; Langel, U.; Genedani, S.; Ferraro, L.; de la Calle, A.; Narvaez, J.; Tanganelli, S.; Woods, A.; Agnati, L.F. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev., 2008, 58, 415-452
47. Carriba, P.; Navarro, G.; Ciruela, F.; Ferré, S.; Casadó, V.; Agnati, L.; Cortés, A.; Mallol, J.; Fuxe, K.; Canela, E.I.; Lluís, C.; Franco, R. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods, 2008, 5, 727-733.
48. Kitano, H. Computational systems biology. Nature, 2002, 420, 206-210.
49. Dunker, A.K.; Brown, C.J.; Obradovic, Z. Identification and functions of usefully disordered proteins. Adv. Protein Chem., 2002, 62, 25-49.
50. Romero P.; Obradovic, Z.; Dunker, A.K. Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform., 1997, 8, 110-124.
51. Radivojac, P.; Obradovic, Z.; Brown, C.J.; Bunker, A.K. Prediction of boundaries between intrinsically ordered and disordered protein regions. Pac. Symp. Biocomput. 2003, 8, 216-227.
52. Linding, R.; Jensen, F.; Diella, P.; Bork, T.; Gibson, J.; Russell, R.B. Protein disorder prediction: implications for structural proteomics. Structure, 2003, 11, 1453-1459.
53. Vullo, A.; Bortolami, O.; Pollastri, G.; Tosatto, S.C.E. Spritz: a server for the prediction of intrinsically disordered regions in protein sequences using kernel machines. Nucleic Acids Res., 2006, 34, W164-W168.
54. Shimizu, K.; Muraoka, Y.; Hirose, S.; Tomii, K.; Noguchi, T. Predicting mostly disordered proteins by using structure-unknown protein data. BMC Bioinformatics, 2007, 8, 78.
55. Pawar, A.P.; Dubay, K.F.; Zurdo, J.; Chiti, F.; Vendruscolo, M.; Dobson, C.M. Prediction of "aggregation-prone" and "aggregation- susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol., 2005, 350, 379-392.
56. Sánchez de Groot, N. ; Pallarés, I. ; Avilés, F.X. ; Vendrell, J. ; Ventura, S. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct. Biol., 2005, 5, 18.
57. Conchillo-Solé, O.; de Groot, N.S.; Avilés, F.X.; Vendrell, J.; Daura, X.; Ventura, S. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics., 2007, 8, 65.
58. Dunker, A.K.; Cortese, M.S.; Romero, P.; Iakoucheva, L.M. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J., 2005, 272, 5129-5148.
59. González-Maeso, J.; Meana, J.J. Heterotrimeric g proteins: insights into the neurobiology of mood disorders. Curr. Neuropharmacol., 2006, 4, 127-138.
60. Guo, T.; Hobbs, D.W. Privileged structure-based combinatorial libraries targeting G protein-coupled receptors. Assay Drug Dev. Technol., 2003, 1, 579-592.
61. Milligan, G.; Wilson, S.; López-Gimenez, J.F. The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization. J. Mol. Neurosci., 2005, 26, 161-168.
62. Fuxe, K.; Marcellino, D.; Woods, A.S.; Leo, G.; Antonelli, T.; Ferraro, L.; Tanganelli, S.; Agnati, L.F. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia. J. Neural Transm., 2009, 116, 923-939.
63. Fuxe, K.; Celani, M.F.; Martire, M.; Zini, I.; Zoli, M.; Agnati, L.F. l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes. Eur. J. Pharmacol., 1984, 100, 127-130.
64. Ferré, S.; Popoli, P.; Rimondini, R.; Reggio, R.; Kehr, J.; Fuxe, K. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology, 1999, 38, 129-140.
65. Popoli, P.; Pezzola, A.; Torvinen, M.; Reggio, R.; Pintor, A.; Scarchilli, L.; Fuxe, K.; Ferre, S. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology, 2001, 25, 505-513.
66. Ferre, S.; Karcz-Kubicha, M.; Hope, B.T.; Popoli, P.; Burgueno, J.; Gutierrez, M.A.; Casado, V.; Fuxe, K.; Goldberg, S.R.; Lluis, C. Franco, R.; Ciruela, F. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl. Acad. Sci. USA, 2002, 99, 11940-11945.
67. Fuxe, K.; Agnati, L.F.; Jacobsen, K.; Hillion, J.; Canals, M.; Torvinen, M.; Tinner-Staines, B. Staines, W.; Rosin, D.; Terasmaa, A.; Popoli, P.; Leo, G.; Vergoni, V.; Lluis, C.; Ciruela, F.; Franco, R.; Ferre, S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology, 2003, 61, S19-S23.
68. Rodrigues, R.J.; Alfaro, T.M.; Rebola, N.; Oliveira, C.R.; Cunha, R.A. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem., 2005, 92, 433-441.
69. Nishi, A.; Liu, F.; Matsuyama, S.; Hamada, M.; Higashi, H.; Nairn, A.C.; Greengard, P. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl. Acad. Sci. USA, 2003, 100, 1322-1327.
70. Diaz-Cabiale, Z.; Vivo, M.; Del Arco, A.; O'Connor, W.T.; Harte, M.K.; Muller, C.E.; Martinez, E.; Popoli, P.; Fuxe, K.; Ferre, S. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Neurosci. Lett., 2002, 324, 154-158.
71. Coccurello, R.; Breysse, N.; Amalric, M. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology, 2004, 29, 1451-1461.
72. Kachroo, A.; Orlando, L.R.; Grandy, D.K.; Chen, J.F.; Young, A.B.; Schwarzschild, M.A. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J. Neurosci., 2005, 25, 10414-10419.
73. Schwarzschild, M.A.; Agnati, L.; Fuxe, K.; Chen, J.F.; Morelli, M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci., 2006, 29, 647-654.
74. Ferre, S.; Agnati, L.F.; Ciruela, F.; Lluis, C.; Woods, A.S.; Fuxe, K.; Franco, R. Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Res. Rev., 2007, 55, 55-67.
75. Nimchinsky, E.A.; Hof, P.R.; Janssen, W.G.; Morrison, J.H.; Schmauss, C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J. Biol. Chem., 1997, 272, 29229-29237.
76. Agnati, L.F.; Guidolin, D.; Leo, G.; Carone, C.; Genedani, S.; Fuxe, K. Receptor-receptor interactions: history, concepts and implications of a membrane molecular integrative mechanism. Prog. Neurobiol., 2009, (In press).
77. Agnati L.F.; Guidolin D.; Leo G.; Genedani S.; Arhem P.; Forni A.; Andreoli N.; Fuxe K. Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. Curr. Protein Pept. Sci., 2007, 8, 460-470.